Skip to main content
EMBO Molecular Medicine logoLink to EMBO Molecular Medicine
. 2014 Dec 3;6(12):1638. doi: 10.15252/emmm.201404707

Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance

Vincent Flacher, Christoph H Tripp, David G Mairhofer, Ralph M Steinman, Patrizia Stoitzner, Juliana Idoyaga, Nikolaus Romani
PMCID: PMC4287980

Correction to: EMBO Mol Med (2014) 6: 1191–1204. DOI 10.15252/emmm.201303283 | Published online 1 August 2014

The authors apologize for two omissions in the list of citations in their recently published paper. The missing citations by Drobits et al, 2012 and Heib et al, 2007 are as follows:

References

  1. Drobits B, Holcmann M, Amberg N, Swiecki M, Grundtner R, Hammer M, Colonna M, Sibilia M. Imiquimod clears tumors in mice independent of adaptive immunity by converting pDCs into tumor-killing effector cells. J Clin Invest. 2012;122:575–585. doi: 10.1172/JCI61034. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Heib V, Becker M, Warger T, Rechtsteiner G, Tertilt C, Klein M, Bopp T, Taube C, Schild H, Schmitt E, et al. Mast cells are crucial for early inflammation, migration of Langerhans cells, and CTL responses following topical application of TLR7 ligand in mice. Blood. 2007;110:946–953. doi: 10.1182/blood-2006-07-036889. [DOI] [PubMed] [Google Scholar]

Articles from EMBO Molecular Medicine are provided here courtesy of Nature Publishing Group

RESOURCES